The Future of Immunogenicity Testing MasterClass - US edition

An important topic for complex therapeutics like Biologics, Biopharmaceuticals, Biosimilars & ATMPs Wanted for different kind of vaccines, unwanted for a variety of complex Large Biological Entities (LBEs)
 

19-21 March, 2025, Virtual

Time Zone : Eastern Standard Time (EST) - UTC05:00

Overview

Main Benefits or Value Propositions of Attending This Event:
-Learn about cutting-edge advancements in immunogenicity testing, including computational models, and regulatory strategies.
-Gain actionable insights to enhance testing accuracy and successful regulatory submissions.
-Access to advanced resources and case studies
-Stay updated on trends driving the future of precision medicine and biologic safety.

How Attendees Knowledge or Skills Will Be Improved:
-Gain a deeper understanding of modern tools and techniques for immunogenic responses.
-Enhance skills in integrating computational models and latest techniques in immunogenicity testing.
-Develop expertise in navigating regulatory guidelines to ensure compliance and minimize risks.
-Learn to apply advanced in vitro testing methodologies in research, generics, discovery and clinical workflows.

What Sets This Event Apart:
-Focus on the intersection of science and compliance, providing a holistic view of immunogenicity testing advancements.
-Offers practical, future-ready strategies tailored to address industry challenges.
-Emphasis on actionable outcomes through interactive sessions and case studies
-Designed for professionals aiming to stay ahead of trends in biologic safety

#masterclass     #pharmaonlinemasterclass      #glceurope      #globalleadingconferences       #immunogenicity

RECOMMENDATION

Who should attend?

-Analysts, Senior analysts

-Team leads

-Managers

-Scientists

-Associates/Research associates

-Quality associates